The upregulation of hsa-miR-3129 is known to suppress epithelial ovarian cancer through CD44. The CD44 gene is highly expressed in many cancers and regulates metastasis (Sun et al., 2018). This evidence concerns the gene CD44 and ovarian carcinoma.